Press Release - May 17, 2016
Heidelberg, Germany, May 17, 2016 – Affimed (Nasdaq: AFMD) today announced that Dr. Adi Hoess, CEO, will present a corporate overview at the UBS Global Healthcare Conference –New York, to be held May 23-25, 2016.
Dr. Hoess’presentation will take place May 23, 1:00-1:30 p.m. (ET).
To access a simultaneous webcast of Dr. Hoess’ presentation online, log on to https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=78_BOOCR44 or go to the Webcast section on our website.
A replay of the webcast will be available from Affimed’s website for 30 days following the conference. Dr. Hoess’presentation will be available for download in PDF format immediately following the conference presentation.
Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information please visit www.affimed.com.
Caroline Stewart, Head IR
Phone: +1 347 394 6793
Anca Alexandru, Head of Communications, EU IR
Phone: +49 6221 64793341